Article

Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.

Institut National de la Santé et de la Recherche Médicale (Inserm) UMR891, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
Journal of Virology (Impact Factor: 4.65). 11/2011; 86(2):1090-6. DOI: 10.1128/JVI.05444-11
Source: PubMed

ABSTRACT Plasmacytoid dendritic cells (pDCs) respond to viral infection by production of alpha interferon (IFN-α), proinflammatory cytokines, and cell differentiation. The elimination of hepatitis C virus (HCV) in more than 50% of chronically infected patients by treatment with IFN-α suggests that pDCs can play an important role in the control of HCV infection. pDCs exposed to HCV-infected hepatoma cells, in contrast to cell-free HCV virions, produce large amounts of IFN-α. To further investigate the molecular mechanism of HCV sensing, we studied whether exposure of pDCs to HCV-infected hepatoma cells activates, in parallel to interferon regulatory factor 7 (IRF7)-mediated production of IFN-α, nuclear factor kappa B (NF-κB)-dependent pDC responses, such as expression of the differentiation markers CD40, CCR7, CD86, and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and secretion of the proinflammatory cytokines TNF-α and interleukin 6 (IL-6). We demonstrate that exposure of pDCs to HCV-infected hepatoma cells surprisingly did not induce phosphorylation of NF-κB or cell surface expression of CD40, CCR7, CD86, or TRAIL or secretion of TNF-α and IL-6. In contrast, CpG-A and CpG-B induced production of TNF-α and IL-6 in pDCs exposed to the HCV-infected hepatoma cells, showing that cell-associated virus did not actively inhibit Toll-like receptor (TLR)-mediated NF-κB phosphorylation. Our results suggest that cell-associated HCV signals in pDCs via an endocytosis-dependent mechanism and IRF7 but not via the NF-κB pathway. In spite of IFN-α induction, cell-associated HCV does not induce a full functional response of pDCs. These findings contribute to the understanding of evasion of immune responses by HCV.

0 Followers
 · 
137 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: 2013, Т. 3, № 1, с. 49–58 поступила в редакцию 28.08.2012 отправлена на доработку 31.08.2012 принята к печати 03.09.2012 Адрес для переписки: Сысоев Кирилл Александрович, к.м.н., старший научный сотрудник НМЦ по молекулярной медицине МЗ РФ СПбГМУ им. акад. И.П. Павлова 197022, Санкт-Петербург, ул. Льва Толстого, 6/8, СПбГМУ им. акад. И.П. Павлова. Тел.: Резюме. Патогенез хронического гепатита С (ХГС) изучен недостаточно. Механизмы повреждения пе-ченочной паренхимы при ХГС отличаются сложностью и разнообразием. Цитокинам отводится роль посредников в процессах фиброза и хронического воспаления. В настоящей работе с помощью муль-типлексного анализа проведено исследование содержания 27 цитокинов в плазме крови 14 пациентов, страдающих ХГС. Пациентам была проведена биопсия печени, при которой определялась активность воспаления (индекс гистологической активности) и степень фиброза. В качестве контрольной груп-пы изучены образцы плазмы крови 19 практически здоровых лиц. Определялись следующие цитоки-ны: IL-1β, IL-1ra, IL-2, IL-4, TNFα и VEGF. У пациентов с ХГС было выявлено повышенное по сравнению с контрольной группой содержание в плазме крови IL-1ra, IL-6, IL-7, IFNγ, IL-12(p70), IL-4, IL-9, IL-8, IP-10, эотаксина, MCP-1, MIP-1β, TNFα, G-CSF и GM-CSF. Уровни FGF-2 и PDGF-BB у пациентов с ХГС были снижены по сравне-нию с контролем. В зависимости от генотипа вируса гепатита С (3a и 1b), индекса гистологической активности в ткани печени и степени фиброза были выявлены различия в продукции IL-1ra, IL-6, IL-7, IFNγ, IL-12(p70), IL-4, IL-9, IL-8, IP-10, эотаксина, MCP-1, MIP-1β, TNFα, G-CSF и GM-CSF. Выявленные изменения уровня цитокинов в плазме крови у пациентов с ХГС характеризуют раз-личную направленность регуляторных нарушений, что характеризует ХГС как иммунопатологи-ческий процесс. Ключевые слова: хронический вирусный гепатит С, фиброз печени, цитокины, хемокины. Abstract. Pathogenesis of chronic hepatitis C (CHC) remains to be determined. Mechanisms of liver parenchyma damage in patients with CHC are complex and different. Cytokines play the role of intermediaries in the process of fibrosis development and chronic inflammation. In the present study levels of 27 cytokines in the blood plasma of 14 patients with CHC were tested using multiplex analysis. The liver biopsy was performed in all patients to define the activity of inflammation (histological activity index) and the degree of fibrosis. Nineteen samples of blood plasma obtained from healthy individuals were served as a control group in this study. The following cytokines were measured: IL-1β, IL-1ra, IL-2, IL-4, VEGF. In patients with CHC elevated levels of plasma IL-1ra, IL-6, IL-7, IFNγ, IL-12 (p70), IL-4, IL-9, IL-8, IP-10, eotaxin, MCP-1, MIP-1β, TNFα, G-CSF and GM-CSF were found in compare with the control group.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dendritic cells (DCs) are multifunctional cells that are pivotal in immune defense. As such they have been explored as vaccine carriers, largely in cancer immunotherapy and against some infectious diseases including HIV and viral hepatitis. However, while the use of DCs as vaccine carrier has shown some promise in cancer immunotherapy, this approach is laborious and is subject to strict quality control, which makes it expensive. Furthermore, in some individuals chronically infected with HIV, HCV and/or HBV the numbers of circulating DCs are reduced and/or their functions impaired. In vivo expansion and mobilization of DCs with Flt3L in combination with antigen and/or adjuvant targeting to critical DC receptors may be a more effective approach to control viral replication in chronically infected HIV, HBV and/or HCV patients than current DC immunotherapy approaches.
    Expert Review of Clinical Immunology 04/2014; DOI:10.1586/1744666X.2014.907742 · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plasmacytoid dendritic cells (pDC) have been regarded as the "professional type I IFN-producing cells" of the immune system following viral recognition that relies on the expression of TLR7 and TLR9. Furthermore, pDC link the innate and adaptive immune systems via cytokine production and Ag presentation. More recently, their ability to induce tolerance and cytotoxicity has been added to their "immune skills." Such a broad range of actions, resembling the diverse functional features of a Swiss army knife, requires strong and prompt molecular regulation to prevent detrimental effects, including autoimmune pathogenesis or tumor escape. Over the last decades, we and other investigators have started to unravel some aspects of the signaling pathways that regulate the various functions of human pDC. In this article, we review aspects of the molecular regulatory mechanisms to control pDC function in light of their multifaceted roles during immunity, autoimmunity, and cancer. Copyright © 2014 by The American Association of Immunologists, Inc.
    The Journal of Immunology 12/2014; 193(12):5772-5778. DOI:10.4049/jimmunol.1401541 · 5.36 Impact Factor

Full-text (2 Sources)

Download
1 Download
Available from
Mar 6, 2015